Home » Topics » BioWorld Science

BioWorld Science
RSS

Small molecule inhibitors of natural killer group 2D identified at Janssen

April 8, 2022

GPR30 is a therapeutic target in triple-negative inflammatory breast cancer

April 8, 2022

IKZF1 gain-of-function variants tied to T/B cell-related immune dysregulation

April 7, 2022

Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate

April 7, 2022

New TYK2 inhibitors identified by Esker Therapeutics

April 7, 2022

Merck & Co. synthesizes new GLCT-1 inhibitors

April 7, 2022

Aurigene Discovery Technologies presents CREBBP and/or KAT3B inhibitors

April 7, 2022

Sunshine Lake Pharma discloses thyroid hormone receptor beta agonists

April 7, 2022

Medshine Discovery patents new sGC activators

April 7, 2022

Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs

April 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...